Your browser doesn't support javascript.
Implications of COVID-19 pandemic on lung cancer management: A multidisciplinary perspective.
Bakhribah, Hatoon; Zeitouni, Mohammad; Daghistani, Rayyan A; Almaghraby, Hatim Q; Khankan, Azzam A; Alkattan, Khaled M; Alshehri, Salem M; Jazieh, Abdul Rahman.
  • Bakhribah H; Oncology Center, King Fahad Medical City, Riyadh, KSA, Saudi Arabia.
  • Zeitouni M; Pulmonary Division, King Faisal Specialist Hospital and Research Center, Riyadh, KSA, Saudi Arabia.
  • Daghistani RA; Imaging Department, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia.
  • Almaghraby HQ; Dept. of Pathology and Laboratory Medicine, King Abdulaziz Medical City and King Saud University for Health Sciences, MNGHA, Jeddah, KSA, Saudi Arabia.
  • Khankan AA; Interventional Radiology, Imaging Department, King Abdulaziz Medical City, Jeddah, KSA, Saudi Arabia.
  • Alkattan KM; Thoracic Surgery, Alfaisal University, Riyadh, KSA, Saudi Arabia.
  • Alshehri SM; Oncology Department, King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, KSA, Saudi Arabia.
  • Jazieh AR; Oncology Department, King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, KSA, Saudi Arabia. Electronic address: jaziehoncology@gmail.com.
Crit Rev Oncol Hematol ; 156: 103120, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-887065
ABSTRACT
Treatment of patients with lung cancer during the current COVID-19 pandemic is challenging. Lung cancer is a heterogenous disease with a wide variety of therapeutic options. Oncologists have to determine the risks and benefits of modifying the treatment plans of patients especially in situation where the disease biology and treatment are complex. Health care visits carry a risk of transmission of SARS-CoV-2 and the similarities of COVID-19 symptoms and lung cancer manifestations represent a dominant problem. Efforts to modify treatment of lung cancer during the current pandemic have been adapted by many healthcare institutes to reduce exposure of lung cancer patients to SARS-CoV-2. We summarized the implications of COVID-19 pandemic on the management of lung cancer from the perspective of different specialties of thoracic oncology multidisciplinary team.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Lung Neoplasms Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Crit Rev Oncol Hematol Journal subject: Hematology / Neoplasms Year: 2020 Document Type: Article Affiliation country: J.critrevonc.2020.103120

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Lung Neoplasms Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Crit Rev Oncol Hematol Journal subject: Hematology / Neoplasms Year: 2020 Document Type: Article Affiliation country: J.critrevonc.2020.103120